Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I´m not able to verify Nutzen´s position or the opposite, but

<Narrower, not weaker. The new claims may indeed be stronger, but narrower.>

Now we are getting somewhere. If narrower means more definitive, then on this we have agreement. But if more definitive automatically means a smaller net (the Ease analogy), I do not necessarily agree.

<The courts also presume this to be the case. The patent holder has to prove otherwise>

Yes, I just agreed with the narrower view, but I'm at a loss as to what needs to be proved. Either a company infringed or they didn't. A more definitive claim makes that job easier to determine. Now if you are saying that the amendment actually did change the essence of the claim, then yes I agree the patent owner has his work cut out.

<The essence of the claim is changed in my opinion. The technical analysis will take a little bit of time to put together. >

Hopefully putting it togeter meant writing up the analysis not doing it. I, and probably many others here, look forward to reading your analysis. TIA

Opty

Share
New Message
Please login to post a reply